⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PBLS News
Parabilis Medicines, Inc. Common Stock
Parabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026
globenewswire.com
PBLS
Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis
globenewswire.com
PBLS
Form 8-K
sec.gov
PBLS
Form 8-K
sec.gov
PBLS
Parabilis Medicines to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference
globenewswire.com
PBLS
Form 8-K
sec.gov
PBLS
Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors
globenewswire.com
PBLS
Form 8-K
sec.gov
PBLS
REGN
Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
PBLS
REGN
Form 8-K
sec.gov
PBLS
REGN